Dr. David Samadi and His Important Contributions to the Medical World

Dr. David Samadi was born in Iran, and raised in a Jewish Persian community. He and his brother left at the young age of 15. They departed from the country during the Iranian Revolution in 1979. From there, they migrated to London and Belgium where they continued their education. He and his brother then came to the United States where he finished high school in New York.

Samadi went on to attend Stony Brook University to earn a degree in biochemistry on a full scholarship. He earned his M.D from the Stony Brook School of Medicine in 1994. His education also includes a postgraduate education and training in urology, along with proctology at the Albert Einstein College of Medicine. He also completed his oncology fellowship at Memorial Sloan Kettering Cancer Center. His education is extensive, and it complements his ability to provide exceptional medical services. He administers effective treatments through a robotic procedure that he developed.

It serves to provide results without the, usual, harmful side effects of cancer treatment. His need to help people is the result of his childhood, and it is the invention of robotic surgery that helped him gravitate toward his current field. His exposure to robotics in Europe helped him to achieve amazing career advancements in the United States. Of course, his own frustration with present day medical practices also helped to fuel his creative and entrepreneurial mindset.

Dr. Samadi also contributes his success to maintaining a daily schedule throughout the year. He practices breathing techniques, and relaxes as often as he can. He also enjoys backgammon and tennis. He knows the value of exercise. He also knows the importance of being positive always and avoiding negativity, envy, and jealousy. He also leaves himself open to the process that allows him to hatch new ideas.

Whenever an idea comes, he draws a diagram so that he can remember it. He is always open to inspiration that comes from things around him. For instance, he developed is present strategy for preforming surgery by watching an interview of JetBlue’s CEO. Dr. Samadi is living a childhood dream. His life is something that everyone can examine as an example of what a dream and education can accomplish.

Dr. David Samadi Social Media: www.youtube.com/user/RoboticOncology

How Eric Lefkofsky Is Aiming To Reduce The Cost Of Cancer Treatment

Between 1996 and 2013 people in America spent $933 billion more on healthcare. The main reason for this is that patients nowadays get more intense care that can be quite expensive. America has an aging population and there are far more elderly people than there ever has been in the past plus a growing population overall. More people have health issues some of which are quite expensive to treat.

Gerard Anderson works for the Bloomberg School of Public Health at John Hopkins. He says that it has been known for a long time that its the prices of receiving health care that’s driving this increase in spending. Back in 2003 he wrote a research paper about this very topic called, “It’s the Prices, Stupid”.

As an example, prices for treating diabetes have grown dramatically over the years. $64 billion more was spent on this disease than in 1996. Most of this is for pharmaceuticals for people to manage diabetes. Low back and neck pain costs have also gone dramatically up with $57 billion being spent on it. As a portion of the population more people aren’t experiencing these but more people are now having it medically treated than years ago.

One person that is trying to reduce the cost of treating cancer is Eric Lefofsky of Groupon fame. He co-founded another Chicago-based company called Tempus and serves as its chief executive officer. This company, which was founded in 2016, is building a digital platform that will contain the largest library of both clinical and molecular data that is in existence. This enables doctors treating cancer to easily narrow down the best treatment option for each of their patients. The platform takes out much of the guesswork that doctors go through.

The platform that Eric Lefkofsky and his team at Tempus are building will help patients achieve better outcomes as their therapy is individually tailored to their genetic makeup. The software can determine, based on their genetic data and other patients clinical data, what therapies they will respond to best. Over time this will also hopefully reduce the expenses that go into cancer treatment.

Visit More Click Here